Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · IEX Real-Time Price · USD
2.02
-0.08 (-3.81%)
At close: Dec 29, 2023, 4:00 PM
2.03
0.00 (0.25%)
After-hours: Dec 29, 2023, 7:24 PM EST
Aadi Bioscience Stock Forecast
Stock Price Forecast
According to 1 stock analyst, the 12-month stock price forecast for AADI stock stock is $5.00, which predicts an increase of 147.52%. On average, analysts rate AADI stock stock as a buy.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AADI stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $5 | Buy | Maintains | $30 → $5 | +147.52% | Dec 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 15, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $45 → $36 | Strong Buy | Maintains | $45 → $36 | +1,682.18% | Nov 13, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +2,127.72% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +2,127.72% | Jun 8, 2023 |
Financial Forecast
Revenue This Year
24.61M
from 15.22M
Increased by 61.75%
Revenue Next Year
27.77M
from 24.61M
Increased by 12.82%
EPS This Year
-2.54
from -2.69
EPS Next Year
-2.81
from -2.54
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 25.8M | 30.4M | 39.2M | 338.6M | 670.1M | 449.9M |
| Avg | 24.6M | 27.8M | 31.8M | 179.9M | 342.1M | 276.4M |
| Low | 22.8M | 24.5M | 25.6M | 54.1M | 81.0M | 111.2M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | 69.9% | 23.5% | 41.0% | 965.7% | 272.5% | 31.5% |
| Avg | 61.8% | 12.8% | 14.4% | 466.3% | 90.2% | -19.2% |
| Low | 50.1% | -0.5% | -7.7% | 70.3% | -55.0% | -67.5% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | -2.48 | -2.64 | -2.68 | 3.79 | 9.95 | 4.33 |
| Avg | -2.54 | -2.81 | -3.12 | 1.89 | 5.92 | 4.20 |
| Low | -2.51 | -2.89 | -3.41 | 0.09 | 2.09 | 4.04 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 427.5% | -26.9% |
| Avg | - | - | - | - | 213.8% | -29.0% |
| Low | - | - | - | - | 10.6% | -31.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.